High-density lipoproteins: an emerging target in the prevention of cardiovascular disease

被引:19
作者
Cutri, Belinda A.
Hime, Neil J.
Nicholls, Stephen J.
机构
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[2] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[3] Heart Res Inst, Sydney, NSW 2050, Australia
关键词
high-density lipoproteins; cardiovascular disease; atherosclerotic plaque; stabilises lesions;
D O I
10.1038/sj.cr.7310097
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
High-density lipoproteins (HDLs) have been well established to protect against the development of atherosclerotic cardiovascular disease. It has become apparent that in addition to the promotion of reverse cholesterol transport, HDLs possess a number of additional functional properties that may contribute to their beneficial influence on the arterial wall. A number of exciting therapeutic strategies have been developed that target HDL and its ability to protect against the development of atherosclerotic plaque. This paper will review how the promotion of the functional properties of HDL inhibits the formation of atherosclerotic plaque and stabilises lesions in patients with established disease.
引用
收藏
页码:799 / 808
页数:10
相关论文
共 100 条
  • [1] RECOMBINANT APOLIPOPROTEIN-A-I MILANO REDUCES INTIMAL THICKENING AFTER BALLOON INJURY IN HYPERCHOLESTEROLEMIC RABBITS
    AMELI, S
    HULTGARDHNILSSON, A
    CERCEK, B
    SHAH, PK
    FORRESTER, JS
    AGELAND, H
    NILSSON, J
    [J]. CIRCULATION, 1994, 90 (04) : 1935 - 1941
  • [2] Reverse cholesterol transport in man: promotion of fecal steroid excretion by infusion of reconstituted HDL
    Angelin, B
    Parini, P
    Eriksson, M
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2002, 3 (04) : 23 - 30
  • [3] [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360
  • [4] Inflammatory/antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment
    Ansell, BJ
    Navab, M
    Hama, S
    Kamranpour, N
    Fonarow, G
    Hough, G
    Rahmani, S
    Mottahedeh, R
    Dave, R
    Reddy, ST
    Fogelman, AM
    [J]. CIRCULATION, 2003, 108 (22) : 2751 - 2756
  • [5] Lack of effect of serum amyloid A (SAA) on the ability of high-density lipoproteins to inhibit endothelial cell adhesion molecule expression
    Ashby, D
    Gamble, J
    Vadas, M
    Fidge, N
    Siggins, S
    Rye, KA
    Barter, PJ
    [J]. ATHEROSCLEROSIS, 2001, 154 (01) : 113 - 121
  • [6] High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport
    Assmann, G
    Schulte, H
    vonEckardstein, A
    Huang, YD
    [J]. ATHEROSCLEROSIS, 1996, 124 : S11 - S20
  • [7] BADIMON JJ, 1989, LAB INVEST, V60, P455
  • [8] REGRESSION OF ATHEROSCLEROTIC LESIONS BY HIGH-DENSITY-LIPOPROTEIN PLASMA FRACTION IN THE CHOLESTEROL-FED RABBIT
    BADIMON, JJ
    BADIMON, L
    FUSTER, V
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (04) : 1234 - 1241
  • [9] Baker PW, 1999, J LIPID RES, V40, P345
  • [10] Baker PW, 2000, J LIPID RES, V41, P1261